IGF-1 LR3 15mg — Vial Spec, Reconstitution Math & COA

Overview of the 15mg IGF-1 LR3 Vial Standard & Laboratory Demand

The 15mg vial configuration of IGF-1 LR3 is designed primarily for high-density academic and industrial laboratories executing large-scale, repeated assays over extended experimental timelines. Long R3 Insulin-like Growth Factor-1 is an 83-amino-acid analog of human IGF-1, modified by an arginine substitution for glutamic acid at position 3 and a 13-amino-acid N-terminal extension sequence. In preclinical models, these molecular alterations significantly attenuate binding to endogenous IGF-binding proteins (IGFBPs), vastly increasing the free peptide concentration available for interaction with the type 1 IGF receptor (IGF-1R).

Because large-scale cell culture and longitudinal rodent trials require sustained administration across multiple culture plates or experimental cohorts, microgram-scale vials often introduce high inter-vial reconstitution variability. A single high-yield 15mg vial enables investigators to prepare a unified stock solution, standardizing baseline peptide concentrations across broad experimental matrixes. While smaller formats (such as 1mg vials) are widely utilized for acute screening, high-throughput applications rely on the 15mg scale to maintain rigorous experimental repeatability across complex laboratory workflows.

Please note: PX1 Research catalogs standard laboratory sizes including the 1mg format on our primary IGF-1 LR3 product page. High-yield quantities such as the 15mg specification are processed under dedicated batch allocations. Researchers requiring bulk distribution for institutional programs can review options through our wholesale catalog or explore our comprehensive index of research compounds via all peptides.

Biochemical Structure and Receptor Binding Dynamics

Understanding the structural kinetics of IGF-1 LR3 is critical when configuring high-yield stock solutions. Standard wild-type IGF-1 possesses a high affinity for circulating IGFBPs, which regulate its biological availability, half-life, and interaction with the transmembrane IGF-1R tyrosine kinase receptor. The synthetic insertion of the 13-amino-acid extension paired with the Glu3Arg substitution creates steric hindrance and electrostatic repulsion at the IGFBP binding pocket without compromising affinity for the IGF-1R binding domain.

In vitro studies demonstrate that IGF-1 LR3 exhibits an affinity for IGFBP-1 through IGFBP-6 that is up to 1,000-fold lower than native IGF-1. Consequently, when introduced to primary cell lines—such as satellite cells, C2C12 myoblasts, or chondrocytes—IGF-1 LR3 remains predominantly uncomplexed. This allows sustained phosphorylation of the downstream Akt/mTOR and MAPK/ERK signaling cascades, driving protein synthesis pathways and cellular proliferation assays without rapid sequestration by secreted binding proteins.

Because of this enhanced functional potency in vitro, researchers must exercise extreme precision during target concentration calculations. Utilizing exact dilution protocols ensures that experimental endpoints reflect controlled receptor activation rather than non-specific cellular stress or receptor downregulation resulting from extreme peptide overload.

Reconstitution Math for a 15mg IGF-1 LR3 Vial

Reconstituting a 15mg lyophilized peptide cake requires precise volumetric measurement to establish known working concentrations. Depending on target pipetting volumes and assay sensitivity, laboratory personnel typically utilize 1.0 mL, 2.0 mL, or 3.0 mL of primary reconstitution vehicle. To calculate final stock concentration (C), divide total peptide mass (M = 15 mg or 15,000 µg) by total liquid volume (V).

When adding 1.0 mL of reconstituting diluent, the resulting concentration is 15.0 mg/mL (15.0 µg/µL or 15,000 µg/mL). This highly concentrated stock is ideal for minimal-volume storage in ultra-low temperature freezers, minimizing aliquot tube requirements. A micro-pipetted volume of 10 µL delivers exactly 150 µg of active peptide compound into working assay media.

When adding 2.0 mL of diluent to the 15mg vial, the resulting concentration is 7.5 mg/mL (7.5 µg/µL or 7,500 µg/mL). This intermediate concentration balances volumetric accuracy with container space, providing easy sub-aliquoting metrics where a 20 µL micro-volume yields 150 µg. For larger volumetric pipetting procedures, adding 3.0 mL of diluent yields a final concentration of 5.0 mg/mL (5.0 µg/µL or 5,000 µg/mL), where 100 µL provides 500 µg.

To quickly verify custom volumes and working assay dilutions without manual calculation error, laboratory staff should utilize our interactive reconstitution calculator tool before preparing stock containers.

Solvent Selection & Solubilization Protocol

Lyophilized IGF-1 LR3 is highly hydrophobic compared to smaller linear peptides. Direct reconstitution of a 15mg mass using neutral pH aqueous solutions—such as standard Phosphate-Buffered Saline (PBS) or 0.9% Sodium Chloride—frequently leads to immediate visible precipitation, peptide aggregation, or hydrophobic adhesion to vial walls. To ensure complete dissolution and preserve tertiary structure, a low-pH primary solvent protocol must be observed.

The standard laboratory solubilization protocol requires primary reconstitution in sterile 10 mM to 100 mM acetic acid (pH 2.5 to 3.0). The acidic environment protonates basic amino acid residues, overcoming hydrophobic forces and bringing the 83-amino-acid chain completely into solution. For a 15mg vial, researchers should first introduce 100 µL to 500 µL of sterile 10 mM acetic acid, allowing the lyophilized cake to fully dissolve via gentle side-wall swirling without vortexing.

Once completely dissolved in the acidic vehicle, the solution can be further diluted with sterile 0.9% Sodium Chloride or Bacteriostatic Water containing 0.9% benzyl alcohol for short-term working stocks. If secondary dilution into neutral buffers like PBS or cell culture media is required, it must be performed immediately prior to assay administration to prevent slow, pH-dependent aggregation over extended storage periods.

Aliquot Planning & Temperature-Controlled Storage Kinetics

Repeated freeze-thaw cycles break peptide backbone bonds and accelerate physical denaturation, leading to loss of biological activity and high experimental error. High-yield formats like the 15mg IGF-1 LR3 vial require immediate sub-aliquoting upon initial reconstitution. Once the master stock is prepared in dilute acetic acid, it should be divided into single-use micro-centrifuge tubes (e.g., Polypropylene, low-binding) matching the volume needed for single experimental runs.

Lyophilized vials received from PX1 Research should be stored at -20°C for short-term project storage (up to 12 months) or at -80°C for long-term repository preservation. Reconstituted stock solutions stored in 10 mM acetic acid maintain physical stability at -80°C for up to 6 to 12 months, provided freeze-thaw events are strictly avoided. Working aliquots diluted in bacteriostatic vehicle and held at 2°C to 8°C should be consumed within 21 to 28 days.

Always handle reconstituted vials under sterile laminar flow hoods to prevent microbial colonization, particularly when working with extended multi-week cell culture protocols. Avoid exposing reconstituted solutions to strong ultraviolet light or elevated temperatures, as oxidation of methionine and tryptophan residues will degrade compound integrity.

Analytical Certificate of Analysis (COA) Specifications & Purity Criteria

Given the structural complexity of recombinant 83-amino-acid proteins, multi-tier analytical verification is mandatory. PX1 Research subjects every production lot of IGF-1 LR3 to rigorous third-party analytical testing prior to release. Every order is paired with a lot-matched Certificate of Analysis detailing essential biochemical parameters.

Purity is measured using High-Performance Liquid Chromatography (HPLC) coupled with UV detection. Authentic research-grade IGF-1 LR3 must exhibit a major peak chromatographic purity exceeding 98.0%. Mass confirmation is established via Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF), confirming the theoretical molecular weight of approximately 9,111 Da within tight mass tolerance limits.

Furthermore, because IGF-1 LR3 is frequently introduced to sensitive cell culture assays, bacterial endotoxin content is quantified using Chromogenic Reagent Endotoxin Testing (LAL assay). PX1 Research guarantees endotoxin levels strictly below <0.05 EU/mg, preventing lipopolysaccharide-induced inflammatory signaling or cell death during in vitro experimentation. Investigators can review analytical protocols and verify batch authenticity on our dedicated COA documentation portal.

Comparative Analysis: IGF-1 LR3 vs. Growth-Promoting Analogs

When structuring preclinical investigations targeting cell growth, hypertrophy, or tissue repair pathways, researchers often evaluate several distinct analogs to determine the optimal experimental tool. Understanding the functional differences between IGF-1 LR3, short-acting variants, and GH-secretagogue peptides ensures correct model selection.

Compared to short-acting variants such as IGF-1 DES—which lacks the N-terminal 3-amino-acid sequence and exhibits high localized activity with an extremely short biological half-life—IGF-1 LR3 provides extended systemic stability suitable for continuous cellular bath protocols. Conversely, peptides that operate higher up the endocrine axis, such as growth hormone releasing analogs like CJC-1295 No DAC, stimulate endogenous pituitary release of wild-type GH, which subsequently induces hepatic production of native, IGFBP-bound IGF-1.

For directly evaluating downstream structural signaling independently of pituitary function, recombinant variants like IGF-1 LR3 or splice variants such as PEG-MGF provide precise control over direct receptor activation. Comparing these distinct mechanisms allows researchers to dissect localized autocrine/paracrine growth signaling versus systemic endocrine cascades in laboratory models.

Selection Framework: When to Choose 15mg vs. Standard Vial Sizes

Selecting the correct unit mass depends entirely on the design, frequency, and scale of the planned laboratory assay. The 15mg format is cost-effective and operationally efficient for large-scale institutional projects, but smaller formats may be more appropriate for lower-throughput applications.

Choose a 15mg vial configuration when conducting high-density multi-well cell proliferation assays, continuous automated microfluidic culture studies, or longitudinal multi-cohort animal experiments requiring daily administration over several weeks. A single reconstituted batch eliminates lot-to-lot and vial-to-vial concentration variance across large data sets.

Choose standard smaller formats (such as 1mg vials available via our main catalog) when executing exploratory pilot studies, short-duration binding assays, or single-plate cell experiments. Utilizing smaller fill sizes prevents waste and minimizes the risks associated with long-term storage or unexpected contamination of large master stock solutions. Additional insights into peptide selection criteria across diverse experimental domains can be found in our research library hub.

PX1 Research Supply Chain, Manufacturing Integrity & Quality Standards

PX1 Research operates strictly as a supplier of high-purity research compounds for scientific and laboratory applications. All peptides are synthesized within ISO 17025 accredited, GMP-compliant facilities located in the United States. Advanced solid-phase peptide synthesis (SPPS) and recombinant expression technologies are combined with multi-step chromatographic purification to eliminate truncated sequence contaminants and residual reagents.

Orders are fulfilled directly from our centralized logistics centers in California and Arizona. Orders placed Monday through Friday prior to cutoff times ship same-day, utilizing temperature-controlled, secure packaging to maintain compound integrity during transit. Every vial is vacuum-sealed with flip-off aluminum seals and stoppers engineered to resist solvent degradation.

By enforcing strict USA-based manufacturing standards and providing full batch transparency through third-party analytical testing, PX1 Research provides primary research institutions, biotechnology firms, and university laboratories with dependable, highly reproducible chemical reagents for cutting-edge scientific inquiry.